C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings

Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
11/2004
11/18/2004	WO2004099175A2 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	WO2004099165A2 Heterocyclic compounds and hydro isomers thereof
11/18/2004	WO2004099164A1 Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection
11/18/2004	WO2004099146A1 Benzamide inhibitors of the p2x7 receptor
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	US20040229952 a thiohydrazide product compound prepared by reacting a hydrazide starting compound with a thionylating reagent; anticancer agents
11/18/2004	US20040229910 Therapeutic compounds
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004	CA2524511A1 Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
11/17/2004	EP1476421A2 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
11/17/2004	EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004	EP1430037A4 Zonisamide intermediate and synthesis
11/17/2004	EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/16/2004	US6818635 For therapy of bacterial infections and neoplasms,
11/11/2004	WO2004096795A2 C-fms kinase inhibitors
11/11/2004	WO2004096230A1 Remedy for rheumatoid arthritis
11/11/2004	WO2004075864A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
11/11/2004	WO2004072052A3 Isoxasole-containing thiourea inhibitors useful for treatment of varicella zoster virus
11/11/2004	WO2003059258A3 Compositions and methods for treating heart failure
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040224992 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
11/11/2004	US20040224928 For therapy of bacterial infections and neoplasms,
11/11/2004	US20040224925 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
11/11/2004	US20040224924 Programming a specific course and rate for a parent drug compound's metabolism that leads to an inactive or weakly active and non-toxic metabolite when the parent drug compound is administered, comprising modifying the parent drug compound by forming one or more of a predetermined chemical arrangement
11/11/2004	US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004	CA2536964A1 C-fms kinase inhibitors
11/10/2004	EP1475092A1 Blockers of the quorum sensing system of Gram-negative bacteria
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1544420A Inhibition of raf kinase using substituted heterocyclic ureas
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/04/2004	WO2004094393A1 Phospholipase inhibitors
11/04/2004	WO2004094384A2 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004	CA2523232A1 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
11/03/2004	EP1473035A1 Leflunomide of high purity
11/03/2004	EP1472236A1 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
11/03/2004	EP1237881B1 Herbicidal halogenalkyl-substituted 3-(4,5-dihydroisoxazol-3-yl)-benzoyl-cyclohexenones
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1542005A Preparation method and use of sulfalene oxazole derivative
11/02/2004	CA2094806C Aminosulfonyl urea acat inhibitors
10/2004
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004071442A3 Novel bicyclic compounds and compositions
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004	US20040214870 Protein-tyrosine phosphatase inhibitors and uses thereof
10/28/2004	US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/27/2004	EP1471064A1 Coumarin derivatives, process for their production and use thereof
10/27/2004	EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	CN1541205A Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring
10/26/2004	US6809204 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
10/26/2004	US6809111 Antiinflammatory agents; analgesics
10/26/2004	US6809107 Neurodegenerative diseases
10/26/2004	CA2211534C Isoxazolyl-benzoyl derivatives
10/21/2004	WO2004089882A2 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
10/21/2004	WO2004089366A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004	WO2004014370A3 Oxadiazoles as modulators of metabotropic glutamate receptor-5
10/21/2004	US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004	US20040209936 Compounds that modulate PPAR activity and methods of preparation
10/21/2004	CA2521907A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004	CA2521653A1 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
10/20/2004	EP1468990A1 Piperazine derivative
10/20/2004	EP0907625A4 Fluorous reaction and separation systems
10/20/2004	CN1171846C Diterpene derivatives and anti-inflammatory analgesic agents comprising the same
10/19/2004	US6806373 Dissolving leflunomide in a solvent to form a leflunomide solution, crystallizing leflunomide form iii from the leflunomide solution, and isolating leflunomide form iii, useful for the treatment of rheumatoid arthritis
10/19/2004	US6806365 N-alkanoylphenylalamine derivatives
10/14/2004	WO2004087683A1 Novel crystalline forms of valdecoxib
10/14/2004	WO2004087682A1 Novel crystalline forms of parecoxib sodium
10/14/2004	WO2004078116A3 P38 inhibitors and methods of use thereof
10/14/2004	WO2004024939A3 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
10/14/2004	US20040204502 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
10/14/2004	US20040204477 For use as antiproliferative agents
10/14/2004	US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
10/14/2004	US20040204464 Isoxazoline compounds having MIF antagonist activity
10/14/2004	US20040204452 to decompose peroxynitrite anion into harmless nitrate or nitrite endproducts which prevents the free radical-mediated cell damage; cytoprotective; Alzheimer's disease; 3,5-dimethylisoxazole-4-sulfonic acid 4-pyrrolidin-1-ylphenylamide
10/14/2004	US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/14/2004	US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine
10/14/2004	US20040204320 used as herbicides
10/13/2004	EP1466891A1 Carboxylic acid derivative
10/13/2004	EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
10/13/2004	EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004	EP1465638A2 Phosphate transport inhibitors
10/13/2004	EP1077956B1 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity
10/13/2004	CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004	CN1535960A Chemical synthesis method of 3-(2-chlorophenyl)-5-methyl-4-isoxazole formyl chloride
10/13/2004	CN1535959A Chemical synthesis method of 3-phenyl-5-methylisoxazole-4-formyl chloride
10/13/2004	CN1170825C Isoxazoline derivatives and herbicides containing same as active ingredient
10/13/2004	CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004	US6803384 Diaminopropionic acid derivatives
10/07/2004	WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same

1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 115